Clinical Trials · NCT01269034
New Onset Type 1 Diabetes: Role of Exenatide
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Albert Einstein College of Medicine
- Enrollment
- 13
- Start date
- Dec 2010
- Locations
- 1 site, United States
- Primary endpoint
- The Role of Exenatide as Compared to Insulin Monotherapy in Reducing Postprandial Hyperglycemia.